{"created_at": "2022-07-30T10:25:06.000Z", "edit_history_tweet_ids": ["1553325808089190401"], "author_id": "1478219847758540802", "id": "1553325808089190401", "text": "$ABBV  Top analyst price target for next week.~ https://t.co/stBZiSEGK0"}
{"text": "RT @Press_Reach: AbbVie Shares Decline After Mixed Q2 Performance \ud83d\ude2c\ud83d\ude2c $ABBV #Abbvie #ABBV #pharmaceuticalstocks #BigPharma #stockinvesting #\u2026", "id": "1553517241542627328", "edit_history_tweet_ids": ["1553517241542627328"], "created_at": "2022-07-30T23:05:47.000Z", "author_id": "1551268969021161473"}
{"created_at": "2022-07-30T00:33:35.000Z", "edit_history_tweet_ids": ["1553176947890737152"], "author_id": "43680740", "id": "1553176947890737152", "text": "7/30\n\u30a8\u30cd   7% $XOM\n\u7d20\u6750 19% $NUE $RIO\n\u8cc7\u672c  10% $DOV $TRTN\n\u4e00\u822c   5% $MCD\n\u5fc5\u9700 14% $KO $MO\n\u533b\u7642 10% $JNJ $ABBV $GILD\n\u60c5\u5831   7% $MSFT $AAPL\n\u901a\u4fe1  10% $VZ\n\u91d1\u878d    9% $AFL\n\u516c\u76ca    9% $NEE $NFG\n\n\u8cfc\u5165:RIO\u3001MO\u3001VZ\n\u58f2\u5374:\u306a\u3057\nCF\u7387:30%\n\u542b\u307f:$23%\u3001\u00a543%\n\u5229\u56de\u308a$4.2%\u3001\u00a54.9% https://t.co/Of2p8RZwc0"}
